Why One Key Analyst Thinks Beverage Stocks Are About to Slow Down
24/7 Wall St. has taken a close look at a recent report from BMO Capital Markets and how it views the beverage industry and where these stocks stand to go from here.
All Work
Chris Lange
How Carvana Won Big in Its First Post-IPO Earnings
Carvana has reported its first quarterly financial results since the company came public in late April.
Will Mayweather-McGregor Be the Highest Valued Fight of All-Time?
Floyd "Money" Mayweather and Connor McGregor, both highly esteemed fighters in their own right, have been dancing around and toward each other over the past year, working to what is one of most highly…
How Calithera Biosciences Won Big With Its Cancer Treatment
Calithera Biosciences shares made a decent gain early on Wednesday after the company announced that it had been granted a Fast Track Designation by the FDA.
Is Inovio Pharma’s Zika Vaccine the Next Big Thing?
Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika virus study.
Ambarella Earnings Aren’t Enough for Investors
Ambarella, Inc. (NASDAQ: AMBA) reported its fiscal first-quarter financial results after the markets closed on Tuesday. The company said that it had $0.39 in earnings per share (EPS) and $64.1 million in revenue, compared…
Tuesday’s Biggest Winners and Losers in the S&P 500
Overall Tuesday was again a relatively flat day for the broad markets. Crude oil made an incredible recovery over the course of the day to currently be positive over 1%, oil & gas stocks…
Celldex Therapeutics Sinks Following ASCO Results
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Merrill Lynch’s Top Picks in Robot and AI Stocks
Merrill Lynch has identified eight entry points for investors who want to play the robots and artificial intelligence theme, with some stock picks for each.
Betting on Millennials: Merrill Lynch’s Best Thematic Investment Ideas
These younger generations are embracing diversity, sustainability, globalization, disruptive technology, "peak stuff," new business models and entrepreneurialism like no generation before them.
Why Albany Molecular Is Actually Getting a Very Good Premium
Shares of Albany Molecular Research saw a handy gain on Tuesday after it was announced that the company signed a definitive agreement to be acquired.
Athenex Announces Potential Price Range for IPO
Athenex expects to price 6 million shares in the range of $11 to $13 apiece for an initial public offering is valued up to more than $89 million.
Why Conn’s Bottom-Line Beat Was Not Enough for Investors
Although Conn's reported fiscal first-quarter financial results that were more or less in line with expectations, this was not enough for investors.
Monday’s Biggest Winners and Losers in the S&P 500
Overall Monday was a relatively flat day for the broad markets. Despite crude oil sliding lower on the day, Oil & Gas stocks were relatively mixed, with the likes of Exxon actually posting a…
Juno Therapeutics Sinks Following ASCO Update
Juno Therapeutics aw its shares slide after the company reported updated clinical trial results at the Annual Meeting for the American Society of Clinical Oncology (ASCO).
Merrill Lynch Gets More Bullish on 8 Top Stocks
Merrill Lynch has updated its Bull Trenders List and 24/7 Wall St. has taken a quick look at these companies.
Why Yelp Was Upgraded and Snap Was Downgraded
24/7 Wall St. had the chance to review these analyst reports that are moving some social media stocks on Monday, and we have included some of the highlights.
Why Forestar Shares Are Making a Run
Forestar Group saw its shares make a solid gain to kick off the week after D.R. Horton announced that it aimed to acquire a huge portion of Forestar's outstanding shares.
Aileron Therapeutics Gears Up for IPO
Aileron Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
7 ASCO Stocks Moving on Cancer Study News (Updated)
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.